Canbas Co., Ltd.

Japan

Create a watch for Canbas Co., Ltd.
Total IP 21
Total IP Rank # 72,113
IP Activity Score 1.7/5.0    8
IP Activity Rank # 115,288
Stock Symbol 45750 (tse)
ISIN JP3244570002
Market Cap. 1811725920.0  (JPY)
Industry Biotechnology
Sector Healthcare

Patents

Trademarks

8 0
7 0
6 0
0
 
Last Patent 2025 - Ido/tdo inhibitor
First Patent 2000 - Compositions and methods for inh...

Latest Inventions, Goods, Services

2024 Invention Ido/tdo inhibitor. A compound of formula (I) given below or a pharmaceutically acceptable salt o...
2022 Invention Conjugates binding phosphatidylserine and toll-like receptors. Presented herein, in certain aspec...
Invention Phosphatidylserine-binding conjugates. Presented herein, in certain aspects, are conjugates capab...
2018 Invention Ido/tdo inhibitor. 6 represents, for example, a substituted or unsubstituted aryl group].
Invention Ido/tdo inhibitor. Provided is a compound represented by formula (I) or a pharmaceutically accept...
2016 Invention Peptides and peptidomimetics in combination with t cell activating and/or checkpoint inhibiting a...
2015 Invention Nrf2-based cancer treatment and detection methods and uses. Disclosed herein, inter alia, are me...
Invention Nrf2-based cancer treatment and detection methods and uses. Disclosed herein, inter alia, are met...
2014 Invention Peptides and peptidomimetics in combination uses and treatments for cancer patient subpopulations...
2010 Invention Compounds with anti-cancer activity. Novel substituted azole diones are provided that kill cells,...
2009 Invention Peptide compound and use thereof. The present invention provides a method for the prophylaxis or...
2008 Invention Peptides and peptidomimetics having immune-modulating, anti-inflammatory, and anti-viral activity...
Invention Peptides and peptidomimetics having anti-proliferative activity and/or that augment nucleic acid ...
Invention Compounds that abrogate dna-damage-induced cell cycle g2 checkpoint and/or augment anti-cancer ac...
Invention Compounds that abrogate dna damage induced cell cycle g2 checkpoint and/or augment anti-cancer ac...
2004 Invention Sensitivity test to predict efficacy of anti-cancer therapies. The present disclosure provides me...
Invention Anti-fungal peptidomimetics. The invention relates to compounds including peptides and peptidomim...
Invention Anti-fungal compounds and methods of use. The invention relates to compounds including peptides a...
2003 Invention Compounds that abrogate dna-damage-induced cell cycle g2 checkpoint and/or augment the anti-cance...
2000 Invention Compositions and methods for inhibiting g2 cell cycle arrest and sensitizing cells to dna damagin...